Share on:
Jarrod Klein 7 Nov 2018
Jarrod Klein @jarrodhklein
RT @EVToday: J Mustapha: Lutonix Below-the-Knee Global DCB IDE trial primary safety endpoint 97.8% DCB vs 95.3% PTA P<.0001 @ 30d; primary…
Swipe
This email is in use. If you are already a member of RankingHero.com please use your account to log in!
Share on:
Google+ LinkedIn